GoldenGolden
Adynxx

Adynxx

A biopharmaceutical company developing pain management drugs

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

January 10, 2017
Adynxx raises a $16,000,000 series B round.
January 10, 2017
Adynxx raises a $16,000,000 series B round from TPG Biotech.
January 2017
Adynxx raises a $16,000,000 series B round from Domain Associates and TPG Biotech.
January 11, 2011
Adynxx raises a $4,800,000 series A round.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Adynxx Funding Round 2017
16,000,000
January 10, 2017
5 Results
Results per page:
Page 1 of 1

SBA Awards

SBA Award
Agency
Award Type
Amount (USD)
Date Awarded
Adynxx, Inc. SBIR Phase I Award, September 2019
SBIR
602,516
September 30, 2019
1 Result
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

George Barnett

Investor

William Martin

Employee

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.